Approval of 2021 third quarter consolidated financial
reports by the Board of Directors
Date of events
2021/11/09
To which item it meets
paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
directors:2021/11/09
2.Date of approval by the audit committee:2021/11/09
3.Start and end dates of financial reports or annual self-assessed financial
information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2021/01/01~2021/09/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):453,050
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):148,934
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):(49,267)
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):25,164
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):7,930
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):2,803
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):0.01
11.Total assets end of the period (thousand NTD):2,828,242
12.Total liabilities end of the period
(thousand NTD):634,222
13.Equity attributable to owners of parent end of the
period (thousand NTD):2,152,188
14.Any other matters that need to be specified:None
Attachments
Original document
Permalink
Disclaimer
Microtek International Inc. published this content on 09 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 November 2021 08:32:08 UTC.
Microtek International, Inc. is a Taiwan-based company principally engaged in the design, manufacture and sales of image scanners and its related applications. The Company operates through two segments. Image Scanners segment is engaged in the design, manufacture and sales of digital image input and output devices. Its products include image scanners for commercial use, for medical use, for biotechnical use and for industrial use, among others. Photoelectron Equipment segment is engaged in the research, manufacture and sales of optical passive devices, optical instrumentations and other photoelectron equipment. Through its subsidiaries, the Company is also involved in the sales of medical equipment, as well as the development and consultancy of related technologies.